Switch Therapeutics Expands Leadership Team with Key Appointmentscarndev2023-05-08T14:27:21+00:00May 8th, 2023|
Advent International Appoints Biopharma Executive James Mullen as Operating Partnercarndev2023-05-08T14:10:25+00:00May 8th, 2023|
